American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
American Journal of Infectious Diseases and Microbiology. 2021, 9(2), 32-38
DOI: 10.12691/ajidm-9-2-1
Open AccessArticle

Toxoplasmosis: An Emerging and Re-emerging Zoonosis of Global Public Health Concern

Mahendra Pal1, , Gemechu Berhanu2, Carl H.D. Steinmetz3 and Nino Durglishvili4

1Narayan Consultancy on Veterinary Public Health and Microbiology, Anand, Gujarat, India

2College of Agriculture and Veterinary Medicine, Dambi Dollo University, Ethiopia

3Expats and Immigrants B.V., Amsterdam, Netherlands

4Ivane Javakhishvili Tbilisi State University, Department of Sociology and Social Work, Vazha Pshavela Ave 25a, Tbilisi, 0177 Georgia

Pub. Date: April 09, 2021

Cite this paper:
Mahendra Pal, Gemechu Berhanu, Carl H.D. Steinmetz and Nino Durglishvili. Toxoplasmosis: An Emerging and Re-emerging Zoonosis of Global Public Health Concern. American Journal of Infectious Diseases and Microbiology. 2021; 9(2):32-38. doi: 10.12691/ajidm-9-2-1


Toxoplasmosis is an important emerging and re-emerging zoonotic disease that results from the infection with Toxoplasma gondii, which is one of the most common parasites in the world. The disease usually happens through consuming undercooked contaminated meat, exposure from diseased cat feces, or mother-to-child transmission all through pregnancy. Toxoplasmosis is commonly transmitted via the mouth when Toxoplasma gondii oocysts or tissue cysts are eaten by chance. Congenital transmission from mother to fetus can also arise. Transmission can arise from the stable organ transplant manner or hematogenous stem cellular transplants. The majority of individuals infected with toxoplasmosis, has no signs and symptoms and is not aware of being infected. However, some people show symptoms and signs similar to those of the flu, inclusive of body aches, swollen lymph nodes, headache, fever, fatigue, confusion, poor coordination, and seizures. Diagnosis of toxoplasmosis in human beings is made through organic, serological, histological, or molecular techniques, or with the aid of combining these techniques. The treatment is commonly encouraged for humans with serious health issues, inclusive of human beings with HIV.The infection may be prevented by eating of cooked meat, drinking wholesome potable water, pasteurization of milk, cleaning of vegetables, wearing gloves when gardening, periodic examination of pregnant women, and health education to the public about the reservoir of infection, mode of transmission and hazards of consuming raw meat.

cat meat protozoa public health Toxoplasma gondii women zoonosis

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Pal, M. (2005). Importance of zoonoses in public health. Indian Journal of Animal Sciences, 75: 586-591.
[2]  Pal, M. (2007). Zoonoses. 2nd Edition. Satyam Publishers, Jaipur, India.
[3]  Pal, M. (2013). Public health concern due to emerging and re-emerging zoonoses. International Journal of Livestock Research, 3: 56-62.
[4]  Pal, M. and Mahendra, R. (2015). Swine flu: A highly infectious emerging viral zoonosis. Ethiopian International Journal of Multidisciplinary Research 2: 51-53.
[5]  Pal, M. (2018). Severe acute respiratory syndrome: A newly recognized viral zoonosis of public health concern. Acta Scientific Microbiology, 1:1.
[6]  Pal, M. (2021). Hendra virus disease: A highly infectious emerging anthropozoonosis. Acta Scientifc Microbiology, 4: 29-30.
[7]  Chhabra, M.B. andMuraleedharan, K. (2016). Parasitic zoonoses and role of wildlife: an overview. Veterinary Research, 4: 1-11.
[8]  Pal, M. (2020). Amoebiasis: an important foodborne disease of global public health concern. Achieves of Nutrition and Public Health, 2: 1-3.
[9]  Muhie, Y. and Kebkes, S. (2014). Toxoplasmosis: Emerging and re-emerging zoonosis. African Journal of Applied Microbiology Research, 3: 1-11.
[10]  Ibrahim, A.M. and Abakar, A.D. (2015). Human toxoplasmosis in the Sudan: A review. European Academic Research, 3(6): 6890-904.
[11]  Montoya, J.G. and Liesenfeld, O. (2004) Toxoplasmosis. The Lancet, 363: 1965-1976.
[12]  Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. (2007). Toxoplasma gondii infection in the United States, 1999–2004, decline from the prior decade. American Journal of Tropical Medicine and Hygiene, 77: 405-410.
[13]  Torok E, Moran E and Cooke F. 2009. Toxoplasmosis. Handbook of Infectious Diseases and Microbiology. Oxford University Press, New York, USA.
[14]  Wang, Z.D., Liu, H.H., Ma, Z.X., Ma, H.Y., Li, Z.Y., Yang, Z.B Zhu, X.Q., Xu, B., Wei, F. and Liu, Q. (2017). Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Frontiers in Microbiology, 8: 389.
[15]  McAuley, J.B. (2014). Congenital toxoplasmosis. Journal of the Pediatric Infectious Diseases Society, 3(1): S30-S35.
[16]  Hussain, M.A., Stitt, V., Szabo, E.A. andNelan, B. (2017). Toxoplasma gondii in the Food Supply. Pathogens, 6(2): 21.
[17]  Dubremetz, J.F. and Lebrun, M. (2012). Virulence factors of Toxoplasma gondii. Microbes and Infection, 14(15): 1403-1410.
[18]  Muralikrishna, P., Sunil, B., Savita, R.K., Archana, S.N., Sudharsan, M., Bharathi, S.V. and Drishya, P. (2017). Toxoplasmosis - The public health significance. International Journal of Science, Environment and Technology, 6 (5): 2752-2758.
[19]  Frenkel, L.D., Gomez, F. and Sabahi, F. (2018). The pathogenesis of microcephaly resulting from congenital infections: why is my baby’s head so small?. European Journal of Clinical Microbiology and Infectious Diseases, 37(2): 209-226.
[20]  Foroutan, M., Dalvand, S., Daryani, A., Ahmadpour, E., Majidiani, H., Khademvatan, S. and Abbasi, E. (2018). Rolling up the pieces of a puzzle: a systematic review and meta-analysis of the prevalence of toxoplasmosis in Iran. Alexandria Journal of Medicine, 54(3): 189-196.
[21]  Hehl, A.B., Basso, W.U., Lippuner, C., Ramakrishnan, C., Okoniewski, M., Walker, R.A., Grigg, M.E., Smith, N.C. and Deplazes, P. (2015). Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. BMC Genomics, 16(1): 1-16.
[22]  Dubey, J.P. (2007). The life cycle of Toxoplasma gondii. Toxoplasma Molecular and Cellular Biology. Norfolk, UK: Horizon Bioscience, 1: 3-16.
[23]  Maenz, M., Schlüter, D., Liesenfeld, O., Schares, G., Gross, U. and Pleyer, U. (2014). Ocular toxoplasmosis past, present and new aspects of an old disease. Progress in Retinal and Eye Research, 39: 77-106.
[24]  Tenter, A.M. (2009). Toxoplasma gondii in animals used for human consumption. Memórias do Instituto Oswaldo Cruz, 104(2): 364-369.
[25]  Tu, V., Yakubu, R. and Weiss, L.M. (2018). Observations on bradyzoite biology. Microbes and Infection, 20(10): 466-476.
[26]  Abdel-Rahman, M.A. (2017). Toxoplasmosis in man and animals. Journal of Chemistry Environmental Health, 3(2): 54-73.
[27]  Moura, M. ., Amendoeira, M.R., and Barbosa, H. S. (2009). Primary culture of intestinal epithelial cells as a potential model for Toxoplasma gondii enteric cycle studies. Memórias do InstitutoOswaldo Cruz, 104(6): 862-864.
[28]  Dubey, J.P. and Jones, J.L. (2008). Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology, 38(11): 1257-1278.
[29]  Tenter, A.M., Heckeroth, A.R. and Weiss, L.M. (2000). Toxoplasma gondii: from animals to humans. International Journal for Parasitology, 30(13): 1217-1258.
[30]  Zhou, P., Chen, Z., Li, H.L., Zheng, H., He, S., Lin, R.Q. and Zhu, X.Q. (2011). Toxoplasma gondii infection in humans in China. Parasites and Vectors, 4(1): 1-9.
[31]  Daryani, A., Sarvi, S., Aarabi, M., Mizani, A., Ahmadpour, E., Shokri, A., Rahimi, M.T. and Sharif, M. (2014).Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Tropica, 137: 185-194.
[32]  Pereira-Chioccola, V. L., Vidal, J. E. and Su, C. (2009). Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology, 4(10): 1363-1379.
[33]  Kodym, P., Malý, M., Beran, O., Jilich, D., Rozsypal, H., Machala, L. and Holub, M. (2015).Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients. Epidemiology and Infection, 143(3): 600-607.
[34]  Arantes, T.E., Silveira, C., Holland, G.N., Muccioli, C., Yu, F., Jones, J.L., Goldhardt, R., Lewis, K.G. and Belfort J.R. (2015). Ocular involvement following postnatally acquired Toxoplasma gondii infection in southern Brazil: a 28-year experience. American Journal of Ophthalmology, 159(6): 1002-1012.
[35]  Rorman, E., Zamir, C.S., Rilkis, I. and Ben-David, H. (2006). Congenital toxoplasmosis prenatal aspects of Toxoplasma gondii infection. Reproductive Toxicology, 21(4): 458-472.
[36]  Saadatnia, G. and Golkar, M. (2012). A review on human toxoplasmosis. Scandinavian Journal of Infectious Diseases, 44(11): 805-814.
[37]  Foerster, B.R., Thurnher, M.M., Malani, P.N., Petrou, M., Carets-Zumelzu, F. and Sundgren, P.C. (2007). Intracranial infections: clinical and imaging characteristics. Acta Radiologica, 48(8): 875-893.
[38]  Ahuja, J. and Kanne, J.P. (2014). Thoracic infections in immunocompromised patients. Radiologic Clinics, 52(1): 121-136.
[39]  Elsheikha, H.M. (2008). Congenital toxoplasmosis: priorities for further health promotion action. Public Health, 122(4): 335-353.
[40]  Pal, M., Alem, B., Gari, G. and Tuli, G. (2014). Toxoplasmosis in animals and humans, its diagnosis, epidemiology and control. International Journal of Livestock Research, 4(2): 1-10.
[41]  Dubey, J.P. (2009). History of the discovery of the life cycle of Toxoplasma gondii. International Journal for Parasitology, 39(8): 877-882.
[42]  Pagmadulam, B., Myagmarsuren, P., Fereig, R.M., Igarashi, M., Yokoyama, N., Battsetseg, B. and Nishikawa, Y. (2018). Seroprevalence of Toxoplasma gondii and Neosporacaninum infections in cattle in Mongolia. Veterinary Parasitology: Regional Studies and Reports, 14: 11-17.
[43]  Opsteegh, M., Haveman, R., Swart, A.N., Mensink-Beerepoot, M.E., Hofhuis, A., Langelaar, M. F.M. and Van der Giessen, J.W. (2012). Seroprevalence and risk factors for Toxoplasma gondii infection in domestic cats in The Netherlands. Preventive Veterinary Medicine, 104(4): 317-326.
[44]  Baneth, G., Thamsborg, S.M., Otranto, D., Guillot, J., Blaga, R., Deplazes, P. and Solano-Gallego, L. (2016). Major parasitic zoonoses associated with dogs and cats in Europe. Journal of Comparative Pathology, 155(1): 54-74.
[45]  Pitter, C., Kahn, J. G., Marseille, E., Lule, J. R., McFarland, D. A., Ekwaru, J. P. Bunnell, R., Coutinho, A. and Mermin, J. (2007). Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes, 44(3): 336-343.
[46]  Flegr, J., Prandota, J., Sovičková, M., and Israili, Z. H. (2014). Toxoplasmosis–a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PloS one, 9(3): e90203.
[47]  Stanić, Ž. and Fureš, R. (2020). Toxoplasmosis: a global zoonosis. Veterinaria, 69(1): 31-42.
[48]  Archibald, L.K. and Quisling, R.G. (2013). Central nervous system Infections. In Textbook of neurointensive care. Springer, London, Pp. 427-517.
[49]  Mathew, S. (2018). Seroprevalence of IgG Toxoplasma in HIV Infected Patients. Journal of Evolution of Medical and Dental Sciences, 7(9): 1148-1152.
[50]  Smith, J.R., Ashander, L.M., Arruda, S.L., Cordeiro, C.A., Lie, S., Rochet, E., Belfort, R. and Furtado, J.M., (2020). Pathogenesis of ocular toxoplasmosis. Progress in Retinal and Eye Research, Pp. 100882.
[51]  Sepúlveda-Arias, J. C., Gómez-Marin, J. E., Bobić, B., Naranjo-Galvis, C. A., and Djurković-Djaković, O. (2014). Toxoplasmosis as a travel risk. Travel Medicine and Infectious Disease, 12(6): 592-601.
[52]  Frenkel, J.K. (2000). Biology of Toxoplasma gondii. In: Ambroise-Thomas P, Peterse E, editors. Congenital toxoplasmosis: scientific background, clinical management and control. Paris: Springer-Verlag, Pp. 9–25.
[53]  Moncada, P.A. and Montoya, J.G. (2012). Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Review of Anti-infective Therapy, 10(7): 815-828.
[54]  Schlüter, D. and Barragan, A. (2019). Advances and challenges in understanding cerebral toxoplasmosis. Frontiers in Immunology, 10: 242.
[55]  Khurana, S. and Batra, N. (2016). Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention. Tropical Parasitology, 6(2): 123.
[56]  Montoya, J.G. (2002). Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. The Journal of Infectious Diseases, 185(1): S73-S82.
[57]  Daryani, A., Sarvi, S., Aarabi, M., Mizani, A., Ahmadpour, E., Shokri, A., Rahimi, M.T. and Sharif, M. (2014). Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Tropica, 137: 185-194.
[58]  Finsterer, J. and Auer, H. (2013). Parasitoses of the human central nervous system. Journal of Helminthology, 87(3): 257.
[59]  Robert-Gangneux, F. and Dardé, M.L. (2012). Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews, 25(2): 264-296.
[60]  Meneceur, P., Bouldouyre, M.A., Aubert, D., Villena, I., Menotti, J., Sauvage, V., Garin, J.F. and Derouin, F. (2008). In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrobial Agents and Chemotherapy, 52(4): 1269-1277.
[61]  Dubey, J.P. (2004). Toxoplasmosis–a waterborne zoonosis. Veterinary Parasitology, 126(2): 57-72.
[62]  Aosai, F., Chen, M., Kang, H.K., Mun, H.S., Norose, K., Piao, L.X., Kobayashi, M., Takeuchi, O., Akira, S. and Yano, A. (2002). Toxoplasma gondii–derived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress and Chaperones, 7(4): 357.
[63]  Kikumura, A., Fang, H., Mun, H.S., Uemura, N., Makino, M., Sayama, Y., Norose, K. and Aosai, F. (2010). Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii derived heat shock protein 70 gene. Parasitology International, 59(2): 105-111.
[64]  De Berardinis, A., Paludi, D., Pennisi, L. and Vergara, A. (2017). Toxoplasma gondii, a foodborne pathogen in the swine production chain from a European perspective. Foodborne Pathogens and Disease, 14(11): 637-648.
[65]  Liu, Q., Wang, Z.D., Huang, S.Y. and Zhu, X.Q. (2015).Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites and Vectors, 8(1): 292.
[66]  Dong, H., Su, R., Lu, Y., Wang, M., Liu, J., Jian, F. and Yang, Y. (2018).Prevalence, risk factors, and genotypes of Toxoplasma gondii in food animals and humans (2000-2017) from China. Frontiers in Microbiology, 9: 2108.
[67]  Kijlstra, A. andJongert, E. (2008). Control of the risk of human toxoplasmosis transmitted by meat. International Journal for Parasitology, 38(12): 1359-1370.
[68]  Atmaca, H.T., Gazyagcı, A.N., Canpolat, S. and Kul, O. (2013). Hepatic stellate cells increase in Toxoplasma gondii infection in mice. Parasites and Vectors, 6(1): 135.
[69]  Hill, D.E. and Dubey, J.P. (2018). Toxoplasma gondii. In Foodborne Parasites. Springer, Cham, pp. 119-138.
[70]  Dubey, J.P. (2020). The history and life cycle of Toxoplasma gondii. In Toxoplasma gondii. Academic Press, Amsterdam, Netherlands. Pp. 1-19.
[71]  Cook, A.J., Holliman, R., Gilbert, R.E., Buffolano, W., Zufferey, J., Petersen, E., Jenum, P.A., Foulon, W., Semprini, A.E. and Dunn, D.T. (2000). Sources of toxoplasma infection in pregnant women: European multicentre case-control study Commentary: Congenital toxoplasmosis—further thought for food. The British Medical Journal, 321: 142-147.
[72]  Andreoletti, O., Budka, H., Buncic, S., Colin, P., Collins, J.D., De, A., Noeckler, B.N., Maradona, M.P., Roberts, T., Vågsholm, I. and Vanopdenbosch, E. (2007). Surveillance and monitoring of Toxoplasma in humans, food and animals scientific opinion of the panel on biological hazards. The European Food Safety Authority Journal, 583: 1-64.
[73]  Sukthana, Y. (2006). Toxoplasmosis: beyond animals to humans. Trends in Parasitology, 22(3): 137-142.
[74]  Aguirre, A.A., Longcore, T., Barbieri, M., Dabritz, H., Hill, D., Klein, P.N., Lepczyk, C., Lilly, E.L., McLeod, R., Milcarsky, J. and Murphy, C.E. (2019). The one health approach to toxoplasmosis: epidemiology, control, and prevention strategies. Eco Health, 16(2): 378-390.